IgA anti-b2GPI antibodies in patients with autoimmune liver diseases

Journal of Clinical Immunology

Volumn 28, Issue 5, 2008, Pages 501-511

  Gabeta, Stella ^a,b   Norman, Gary L ^c   Gatselis, Nikolaos ^a   Liaskos, Christos ^a   Papamichalis, Panagiotis A ^a   Garagounis, Athanasios ^a   Zachou, Kalliopi ^a,b   Rigopoulou, Eirini I ^a,b   Dalekos, George N ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

^c INOVA DIAGNOSTICS INC   (United States)

Author keywords

Anticardiolipin antibodies; Autoimmune hepatitis; Beta 2 glycoprotein I; Liver autoimmunity; Primary biliary cirrhosis; Primary sclerosing cholangitis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; BIOCHEMISTRY; CAUCASIAN; CHILD; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTICARDIOLIPIN; BETA 2-GLYCOPROTEIN I; CHILD; CHOLANGITIS, SCLEROSING; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOGLOBULIN A; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 51349086256     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-008-9211-6     Document Type: Article

References (40)

1. S Miyakis MD Locksin T Atsumi DW Branch RL Brey R Cervera 2006 International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 295 306
2. H Bas de Laat RH Derksen PG de Groot 2004 β2-Glycoprotein I, the playmaker of the antiphospholipid syndrome Clin Immunol 112 161 168
3. T Atsumi O Amengual S Yasuda E Matsuura T Koike 2005 Research around beta2-glycoprotein I: a major target for antiphospholipid antibodies Autoimmunity 38 377 381
4. GN Dalekos MN Manoussakis AC Goussia EV Tsianos HM Moutsopoulos 1993 Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis Gut 34 658 664
5. GN Dalekos K Zachou C Liaskos 2001 The antiphospholipid syndrome and infection Curr Rheumatol Rep 3 277 285
6. C Petrovas PG Vlachogiannopoulos T Kordossis HM Moutsopoulos 1999 Anti-phospholipid antibodies in HIV infection and SLE with or without antiphospholipid syndrome: comparisons of phospholipids specificity, avidity and reactivity with beta2-GPI J Autoimmun 13 347 355
7. GN Dalekos MN Manoussakis E Zervou EV Tsianos HM Moutsopoulos 1993 Immunologic and viral markers in the circulation of anti-HIV negative heroin addicts Eur J Clin Invest 23 219 225
8. K Zachou C Liaskos DK Christodoulou M Kardasi G Papadamou N Gatselis 2003 Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome Eur J Clin Invest 33 161 168
9. GN Dalekos KG Kistis DS Boumba P Voulgari EK Zervou AA Drosos 2000 Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome Eur J Gastroenterol Hepatol 12 67 74
10. M Blank I Krause M Fridkin N Keller J Kopolovic I Goldberg 2000 Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome J Clin Invest 109 797 804
11. C Liaskos E Rigopoulou K Zachou S Georgiadou N Gatselis R Papamihali 2005 Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis J Autoimmun 24 251 260
12. K Zachou C Liaskos E Rigopoulou S Gabeta P Papamichalis N Gatselis 2006 Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases Clin Immunol 119 203 212
13. PG Vlachoyiannopoulos C Petrovas M Tektonidou SA Krilis HM Moutsopoulos 1998 Antibodies to β2glycoprotein I: urea resistance, binding specificity and association with thrombosis J Clin Immunol 18 308 391
14. 2-glycoprotein I antibodies in patients with antiphospholipid syndrome Ann Rheum Dis 63 1478 1482
15. M Samarkos KA Davies C Gordon S Loizou 2006 Clinical significance of IgA anticardiolipin and anti-beta2-GPI antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome Clin Rheumatol 25 199 204
16. GM Iverson CA von Muhlen HL Staub AJ Lassen W Binder GL Norman 2006 Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autantibodies that preferentially target domain 4 of beta2-GPI J Autoimmun 27 266 271
17. G Lakos E Kiss N Regeczy P Tarjan P Soltesz M Zeher 1999 Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype Clin Exp Immunol 117 574 579
18. E Cucurull AE Gharavi E Diri E Mendez D Kapoor LR Espinosa 1999 IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus Am J Med Sci 318 55 60
19. A Pahor R Hojs I Holc A Ambrozic S Cucnik T Kveder 2006 Antiphospholipid antibodies as a possible risk factor for atherosclerosis in patients with rheumatoid arthritis Immunobiology 211 689 694
20. HL Straub M Frank A Ranzolin GL Norman GM Iverson CA vonMuhlen 2006 IgA antibodies to beta2-glycoprotein I and atherosclerosis Autoimmun Rev 6 104 106
21. RM Lee DW Branch RM Silver 2001 Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death Am J Obstet Gynecol 185 748 753
22. S Carmo-Pereira ML Bertolaccini A Escudero-Contreras MA Khamashta GR Hughes 2003 Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity Ann Rheum Dis 62 540 543
23. PA Papamichalis K Zachou GK Koukoulis A Veloni EG Karacosta L Kypri 2007 The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders J Autoimmune Dis 4 3
24. F Alvarez PA Berg FB Bianchi L Bianchi AK Burroughs EL Cancado 1999 International autoimmune hepatitis group: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 929 938
25. EI Rigopoulou ET Davies A Pares K Zachou C Liaskos DP Bogdanos 2005 Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis Gut 54 528 532
26. EI Rigopoulou ET Davies DP Bogdanos C Liaskos M Mytilinaiou GK Koukoulis 2007 Anti-mitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary bilary cirrhosis Liver Int 27 1226 1231
27. EI Rigopoulou DP Bogdanos C Liaskos A Koutsoumpas H Baum D Vergani 2007 Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis Clin Chim Acta 380 118 121
28. S Cullen R Chapman 2003 Primary sclerosing cholangitis Autoimmun Rev 2 305 312
29. DS Kyriakou MG Alexandrakis K Zachou F Passam N Stathakis GN Dalekos 2003 Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis J Hepatol 39 679 685
30. A Tsikrikoni DS Kyriakou EI Rigopoulou MG Alexandrakis K Zachou F Passam 2005 Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis J Hepatol 42 393 399
31. K Zachou EI Rigopoulou A Tsikrikoni MG Alexandrakis F Passam DS Kyriakou 2005 Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production J Autoimmun 25 283 288
32. P Angulo JB Peter ME Gershwin CK DeSotel Y Shoenfeld AE Ahmed 2000 Serum autoantibodies in patients with primary sclerosing cholangitis J Hepatol 32 182 187
33. SS Pierangeli EN Harris 2005 Clinical laboratory testing for the antiphospholipid syndrome Clin Chim Acta 357 17 33
34. K Zachou EI Rigopoulou GN Dalekos 2004 Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical diagnosis and to study pathogenesis of the disease J Autoimmune Dis 1 2
35. AJ Czaja 1999 Behaviour and significance of autoantibodies in type 1 autoimmune hepatitis J Hepatol 30 394 401
36. S Oertelt R Rieger C Selmi P Invernizzi AA Ansari RL Coppel 2007 A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis Hepatology 45 659 665
37. J Wesierska-Gadek E Penner PM Battezzati C Selmi M Zuin E Hitchman 2006 Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis Hepatology 43 1135 1144
38. A Tanaka S Nezu S Uegaki M Mikami S Okuyama N Kawamura 2007 The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis Ann N Y Acad Sci 1107 259 270
39. NM Shah MA Khamashta T Atsumi GR Hughes 1998 Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients Lupus 7 3 6
40. MR Arbuckle MT McClain MV Rubertone RH Scofield GJ Dennis JA James 2003 Development of autoantibodies before the clinical onset of systemic lupus erythematosus New Engl J Med 349 1526 1533